Crescita Therapeutics Inc.
CRRTF
$0.2371
-$0.1155-32.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -649.40K | -115.70K | -759.60K | -676.70K | -464.30K |
| Total Depreciation and Amortization | 246.00K | 260.70K | 228.80K | 222.20K | 285.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.70K | 44.30K | 93.80K | 62.10K | -57.10K |
| Change in Net Operating Assets | 101.70K | 793.70K | 747.80K | 792.20K | 516.20K |
| Cash from Operations | -357.40K | 983.00K | 310.90K | 399.70K | 280.40K |
| Capital Expenditure | -46.00K | -252.20K | -610.00K | -666.50K | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 57.20K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -46.00K | -252.20K | -552.80K | -666.50K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -116.00K | -113.00K | -110.00K | -110.00K | -108.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -43.00K | -77.00K | -117.00K | -48.00K | -78.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -50.00K | -- | -- | -50.00K |
| Cash from Financing | -110.80K | -171.40K | -166.40K | -115.50K | -175.00K |
| Foreign Exchange rate Adjustments | 2.10K | 37.10K | -12.50K | 2.90K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -512.10K | 596.50K | -420.80K | -379.30K | 108.30K |